(Hypertension. 1995;26:137-142.)
© 1995 American Heart Association, Inc.
Articles |
From the Departments of Physiology and Internal Medicine, the University of Michigan, Ann Arbor.
Correspondence to Dr Jürgen Schnermann, University of Michigan, Department of Physiology, Medical Science Bldg II, No 7712, Ann Arbor, MI 48109.
| Abstract |
|---|
|
|
|---|
Key Words: kidney juxtaglomerular apparatus rabbit calcium channels glomerular mesangium
| Introduction |
|---|
|
|
|---|
The present experiments were performed to further characterize MD-dependent renin secretion. Whereas our previous experiments showed that maximum inhibition of renin release was achieved in a limited concentration range,2 these studies did not resolve the profile of the NaCl dependency of renin secretion in the intermediate concentration range. In the present studies, we have developed a method that permits a stepwise increase or decrease in luminal NaCl concentration, enabling us to arrive at a more detailed identification of NaCl-dependent renin secretion.
Loop diuretics have been identified as potent inhibitors of tubuloglomerular feedback responses, the change in vasomotor tone caused by luminal NaCl concentration.4 5 Although we have seen that bumetanide did stimulate renin secretion in the presence of a high NaCl concentration,3 we were concerned that this effect was relatively modest and did not seem to be identical in magnitude to the stimulation caused by a low NaCl concentration. Therefore, in the present experiments, we have examined the effect of a loop diuretic on renin secretion over the entire NaCl concentration range.
Studies in kidney slices and in isolated juxtaglomerular cells showed that verapamil stimulates renin secretion, suggesting that calcium influx through voltage-activated calcium channels might mediate the inhibitory response to an increased luminal NaCl concentration.6 Involvement of calcium channels in MD-mediated responses is indicated by the finding that calcium channel blockers such as verapamil and nifedipine are potent inhibitors of the vascular response to changes in MD NaCl concentration.7 8 On the other hand, direct evidence that calcium influx through voltage-activated calcium channels plays a role in the renin release pathway controlled by MD is lacking. We therefore examined the effect of verapamil on the profile of NaCl-dependent renin secretion.
| Methods |
|---|
|
|
|---|
As a major modification of the standard perfusion technique, the present studies used a method that allowed stepwise changes in perfusate NaCl concentration in the same specimen. Two perfusion solutions were made. The first solution contained (in mmol/L) NaHCO3 25, NaH2PO4 0.96, Na2HPO4 0.24, KCl 5, MgSO4 1.2, CaCl2 1, and glucose 5.5. In this solution, sodium and chloride concentrations were 26 and 7 mmol/L, respectively. The second solution was identical except that it contained an extra 80 mmol/L NaCl so that sodium and chloride were 106 and 87 mmol/L, respectively. The two different NaCl solutions were loaded into two syringes driven by two independent pumps (Razel Syringe Pump, Razel Scientific Instruments). The solutions flowing from the two syringes were mixed in a plastic capillary tube (see Fig 1) so that the NaCl concentration in the mixed solution was determined by the ratio of pump speeds. The mixing in this perfusion system was tested by loading one syringe with saline only and the other with saline and [3H]inulin. The ratio of flows from the two syringes was then changed from 9:1 to 1:9. Perfusate was collected at the tip of the superfusion pipette for 10 minutes at each step for measurement of [3H]inulin concentration. As Fig 1 shows, the observed values were close to the predicted values, indicating that the solutions from the two syringes were fully mixed. The luminal perfusion flow rate of the specimen was controlled by a hydraulic pressure head, which was constant during each experiment. The perfusion flow rate varied between 20 and 100 nL/min between different experiments. The specimens were superfused with DMEM containing 0.3% human serum albumin. Drugs were added to the superfusate by infusion upstream of the specimen through a pipette inserted through the opening of the superfusion cannula. The superfusion flow was controlled by two extra pumps at a final rate of 2 µL/min.
|
The droplet of superfusate, including the perfusate, that had passed through the JGA specimen was collected at 10-minute intervals and frozen for later renin assay. During the experiment, the specimen was maintained at 38°C.
Experimental Protocols
Series 1
To test the relation between MD NaCl concentration and renin
secretion rate, the specimens were perfused with a solution in which
the concentration of Na/Cl was increased stepwise from 26/7 over 46/27,
66/47, and 86/67 mmol/L to 106/87 mmol/L. Thus, NaCl concentration was
raised by 20 mmol/L at each step change. The mixture of the perfusate
and the superfusate was collected for 10 minutes to measure renin
secretion rate.
Series 2
In these studies, each specimen was perfused twice with a
perfusate in which NaCl concentration was increased stepwise as
described above. In either the first or the second period,
5x10-5 mol/L furosemide (American Reagent Laboratories)
was present in the perfusion solution in both pumps.
Series 3
The specimens in this series also were perfused with perfusates
containing increasing concentrations of NaCl. During either the first
or the second period, 10-6 mol/L verapamil
(American Reagent Laboratories) was added to the superfusate to test
the effect of calcium channel blockade on NaCl-induced renin
secretion.
Analytical and Statistical Methods
Renin concentration in the collected droplets was measured by
radioimmunoassay of generated angiotensin I with the
antibody-trapping technique.10 Renin activity is expressed
in standard Goldblatt hog units (GU) by comparison with standard renin
obtained from the Institute for Medical Research (MRC, Holly Hill). In
agreement with earlier studies, renin secretion rate among individual
specimens was found to vary over three orders of
magnitude.1 2 3 Statistical analysis was therefore
performed on log-transformed data. The paired t test was
used to assess statistically significant differences, with a value of
P<.05 considered significant. Average values are given both
as log mean±SEM and arithmetic mean±SEM.
| Results |
|---|
|
|
|---|
|
Series 2
Fig 3 shows data from the experimental series in
which we tested the effect of luminal furosemide at 50 µmol/L on the
NaCl dependency of renin secretion. Control data of this series were
similar to those of series 1. Again, renin secretion rate decreased
exponentially when MD Na/Cl concentration was increased over the
concentration range from 27/7 to 86/67 mmol/L. Application of
furosemide in the perfusate was found to block the renin secretory
response induced by changing MD NaCl concentration. None of the values
was significantly different from renin secretion at the lowest Na/Cl
concentration (Table). Furthermore, the slope of the
log linear function without furosemide (-0.0170±0.0037) was
significantly steeper than that with furosemide (-0.0024±0.0026,
P<.01; Fig 3). As Fig 3 and the Table also show, loss of
NaCl dependency in the presence of furosemide resulted from both a
decrease of renin secretion at low Na/Cl concentrations and an increase
at high Na/Cl concentrations.
|
|
Series 3
In this experimental series, we examined the effect of 1 µmol/L
verapamil in the superfusate on NaCl-dependent renin
secretion. Fig 4 and the Table show the results.
Verapamil was found to markedly attenuate MD NaCl
concentrationinduced renin secretion (Table). The slope of the log
linear function of MD NaClinduced renin secretion in control
(-0.0200±0.0032) was significantly steeper than during
verapamil application (-0.0043±0.0058;
P<.05). This reduction in slope resulted primarily from an
increased renin secretion at high Na/Cl concentrations.
|
| Discussion |
|---|
|
|
|---|
Results from studies in intact animals led Vander11 to suggest that the signal initiating changes in MD-dependent renin secretion is a change in NaCl transport rather than a change in NaCl concentration per se. In a previous study using the isolated JGA preparation, we found that bumetanide, an inhibitor of the Na-2Cl-K cotransporter, stimulated renin release suppressed by high NaCl concentrations when the drug was added to the perfusate but not the bath.3 Furthermore, Itoh and Carretero14 showed that furosemide stimulated renin release in isolated perfused afferent arterioles only when the MD was included in the specimen. The present finding that luminal application of 5x10-5 mol/L furosemide greatly attenuated the inhibition of renin secretion caused by increasing MD NaCl concentrations is fully consistent with the earlier evidence that Na-2Cl-K cotransport is a necessary step in MD-mediated renin release. This concept was strengthened by strong functional evidence in support of the expression of some isoform of the Na-2Cl-K cotransporter in MD cells.15 16
Lorenz et al3 previously noted that bumetanide added to the high NaCl solution caused an approximately threefold increase of renin secretion, whereas a decrease in NaCl concentration in this preparation is associated with an increase of renin secretion by a factor of about 6.2 3 Thus, blockade of transport by bumetanide appeared to be a less powerful stimulator of renin release than a decrease in NaCl concentration. The present data confirm this observation: furosemide in the presence of high NaCl concentrations caused an approximately threefold increase in renin secretion, whereas a reduction in NaCl concentration increased renin secretion by a factor of about 10. In fact, when furosemide was added to the low NaCl concentration, it inhibited rather than stimulated renin secretion. Because it is unlikely that furosemide stimulates NaCl transport in the presence of a low NaCl concentration, it appears that furosemide exerts an effect that is independent of its blockade of the luminal Na-2Cl-K cotransporter. Further studies are needed to clarify the mechanism of this MD transportunrelated effect of furosemide and to identify the cells involved in it. It is of note that furosemide-sensitive transporters are present on both mesangial and vascular smooth muscle cells, so it is feasible that the effect seen at low luminal NaCl concentrations is mediated by an interaction of furosemide with cells in the JGA other than MD cells.17 18 19 It is also of note that furosemide in the present studies does not appear to fully mimic its in vivo effects. As Fig 3 shows, renin secretion rates at NaCl concentrations that may be considered normal in vivo were not different from those at the elevated levels caused by the presence of furosemide. One explanation may be that, under in vivo conditions, renin release is under other influences in addition to MD NaCl concentration and that these factors exert a suppressing effect that is not seen in the isolated preparation. For example, the arterioles in the isolated preparation are not perfused. Thus, differences in arteriolar wall tension and/or the release of endothelial factors may be responsible for lower renin secretory rates at normal NaCl concentrations in vivo than in vitro. It is conceivable that because of lower baseline renin secretions, the stimulatory effect of furosemide is more easily detectable in vivo. Another difference is that in vivo furosemide is present in the vessel lumen, the interstitium, and tubular fluid, whereas it is present only in tubular fluid in our preparation. If furosemide had other effects, eg, direct vascular effects, these could contribute to the stimulatory effect in vivo.
There is substantial support for the notion that a change in [Ca2+]o is a common response of the effector cells controlled by the MD signals.20 21 Intracellular calcium is directly related to smooth muscle tension, and calcium influx through voltage-activated calcium channels is an important mechanism in the activation of afferent arteriolar vascular smooth muscle cells.22 23 That calcium channel blockers such as verapamil and nifedipine are effective blockers of MD-initiated vasoconstriction is consistent with this notion.7 8 Similarly, there is convincing evidence that renin secretion from granular cells is inversely related to intracellular calcium.6 21 Furthermore, studies in kidney slices suggest that an increased calcium flux through voltage-activated calcium channels makes an important contribution to the inhibition of renin secretion caused, for example, by potassium depolarization.24 25 The attenuation of the renin inhibitory effect of increasing MD NaCl concentrations by verapamil in the present study is compatible with the possibility that an increase in MD NaCl concentration causes an increase of cytosolic calcium not only in vascular smooth muscle cells but also in granular cells and that this increase is at least in part the result of an activation of voltage-dependent calcium channels. The cause of this change in granular cell calcium permeability under physiological conditions is not known with certainty but could be related to the NaCl-dependent generation of adenosine or other local mediators with membrane-depolarizing actions.26 This interpretation would have to be reevaluated if recent evidence confirms that granular cells do not express voltage-activated calcium channels.27 28 29
Some experimental evidence supports the concept that adenosine participates in the transmission mechanism of NaCl-dependent renin secretion.26 30 In the context of this theory, it is pertinent to recall that both in vivo and in a kidney slice preparation, verapamil has been found to be without effect on the renin inhibitory action of exogenous adenosine.31 32 The verapamil inhibitability of NaCl-dependent renin secretion in the current studies suggests that adenosine is not a major participant in MD-regulated renin release but that increases in luminal NaCl induce the release of other locally active agents that affect renin release by a mechanism that includes a verapamil-blockable component. Alternatively, it is possible that adenosine generated by MD cells interacts with granular cells indirectly through participation of an intermediary cell and that this indirect interaction is verapamil-sensitive.
In summary, the present experiments demonstrate an inverse exponential relation between renin secretion and MD NaCl concentration in an Na/Cl concentration range between 26/7 and 86/67 mmol/L. [Cl]1/2, the chloride concentration at which the change in renin secretion was half-maximal, was 30 mmol/L. Both furosemide and verapamil greatly attenuated the dependency of renin secretion on MD NaCl concentration, suggesting that in addition to an operative Na-2Cl-K cotransporter, voltage-activated calcium channels are necessary constituents of MD control of renin release. Identification of the cellular localizations of these two critical membrane proteins in this mechanism requires further study.
| Acknowledgments |
|---|
Received November 21, 1994; first decision December 15, 1994; accepted April 13, 1995.
| References |
|---|
|
|
|---|
2.
Lorenz JN, Weihprecht H, Schnermann J, Skøtt O,
Briggs JP. Characterization of the macula densa stimulus for
renin secretion. Am J Physiol. 1990;259:F186-F193.
3.
Lorenz JN, Weihprecht H, Schnermann J, Skøtt O,
Briggs JP. Renin release from isolated
juxtaglomerular apparatus depends on macula
densa chloride transport. Am J Physiol. 1991;260:F486-F493.
4. Schnermann J, Briggs JP. Function of the juxtaglomerular apparatus. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology. 2nd ed. New York, NY: Raven Press Publishers; 1992:1249-1289.
5. Wright FS, Schnermann J. Interference with feedback control of glomerular filtration rate by furosemide, triflocin, and cyanide. J Clin Invest. 1974;53:1695-1708.
6. Churchill PC. Second messengers in renin secretion. Am J Physiol. 1985;249:F175-F184.
7.
Mitchell KD, Navar LG.
Tubuloglomerular feedback responses during
peritubular infusions of calcium channel blockers. Am J
Physiol. 1990;258:F537-F544.
8. Müller-Suur R, Gutsche HU, Schurek HJ. Acute and reversible inhibition of tubuloglomerular feedback mediated afferent vasoconstriction by calcium-antagonist verapamil. In: Schmidt U, Dubach U, eds. Current Problems in Clinical Biochemistry, Renal Metabolism in Relation to Renal Function. Bern, Switzerland: H Huber; 1977:291-298.
9. Skøtt O, Briggs JP. A method for superfusion of the isolated perfused tubule. Kidney Int. 1988;33:1009-1012. [Medline] [Order article via Infotrieve]
10. Lykkegard S, Poulsen K. Ultramicroassay for plasma renin concentration in the rat using the antibody-trapping technique. Anal Biochem. 1976;75:250-259. [Medline] [Order article via Infotrieve]
11.
Vander AJ. Control of renin release.
Physiol Rev. 1967;47:359-382.
12. Wong NLM, Quamme GA. Association of calcium and sodium handling in the rabbit nephron: a micropuncture study. Renal Physiol Biochem. 1990;13:306-313. [Medline] [Order article via Infotrieve]
13. Wong NLM, Whiting SJ, Mizgala CL, Quamme GA. Electrolyte handling by the superficial nephron of rabbit. Am J Physiol. 1986;250:F590-F595.
14. Itoh S, Carretero OA. Role of macula densa in renin release. Hypertension. 1985;7(part II):II-49-II-54.
15.
Lapointe JY, Bell PD, Cardinal J. Direct
evidence for apical
Na+-K+-Cl-
co-transport in macula densa cells. Am J Physiol. 1990;258:F1466-F1469.
16. Schlatter E, Salomonsson M, Persson AEG, Greger G. Macula densa cells sense luminal NaCl concentration via furosemide sensitive Na+2Cl-K+ cotransport. Pflugers Arch. 1989;414:286-290. [Medline] [Order article via Infotrieve]
17.
Homma T, Hoover RL, Harris RC. Loop
diuretic-sensitive potassium flux pathways of rat
glomerular mesangial cells. Am J
Physiol. 1990;258:C862-C870.
18.
Kasner SE, Ganz MB. Regulation of intracellular
potassium in mesangial cells: a fluorescence
analysis using the dye PBFI. Am J Physiol. 1992;262:F462-F467.
19. Owen NE. Regulation of Na/K/Cl cotransport in vascular smooth muscle cells. Biochem Biophys Res Commun. 1984;125:500-508. [Medline] [Order article via Infotrieve]
20. Briggs JP, Schnermann J. Macula densa control of renin secretion and glomerular vascular tone: evidence for common cellular mechanisms. Renal Physiol Biochem. 1986;9:193-203.
21.
Hackenthal E, Paul M, Ganten D, Taugner R.
Morphology, physiology, and molecular biology of renin
secretion. Physiol Rev. 1990;70:1067-1116.
22.
Carmines PK, Navar LG. Disparate effects of Ca
channel blockade on afferent and efferent arteriolar responses to ANG
II. Am J Physiol. 1989;256:F1015-F1020.
23. Siegel G, Scheider W. Anions, cations, membrane potential and relaxation. In: Vanhoutte PM, Leusen I, eds. Vasodilation. New York, NY: Raven Press Publishers; 1981:285-298.
24. Park CS, Han DS, Fray JCS. Calcium in the control of renin secretion: Ca2+ influx as an inhibitory signal. Am J Physiol. 1981;240:F70-F74.
25. Churchill PC, Churchill MC. Ca-dependence of the inhibitory effect of K-depolarization on renin secretion from rat kidney slices. Arch Int Pharmacodyn Ther. 1982;258:300-312. [Medline] [Order article via Infotrieve]
26. Spielman WS, Thompson CI. A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol. 1982;242:F423-F435.
27.
Kurtz A, Penner R. Angiotensin II
induces oscillations of intracellular calcium and blocks
anomalous inward rectifying potassium current in mouse renal
juxtaglomerular cells. Proc Natl Acad Sci
U S A. 1989;86:3423-3427.
28. Kurtz A, Skøtt O, Chegini S, Penner R. Lack of direct evidence for a functional role of voltage-operated calcium channels in juxtaglomerular cells. Pflugers Arch. 1990;416:281-287. [Medline] [Order article via Infotrieve]
29. Greenberg SG, Yule DI, He XR, Briggs JP, Schnermann J. Inhibition of renin secretion by K depolarization is mediated by calcium channels on mesangial cells. Nieren-und Hochdruckkrankheiten. 1993;22:486. Abstract.
30. Weihprecht H, Lorenz JN, Schnermann J, Skøtt O, Briggs JP. Effect of adenosine1-receptor blockade on renin release from rabbit isolated perfused juxtaglomerular apparatus. J Clin Invest. 1990;85:1622-1628.
31. Arend LJ, Haramati A, Thompson CI, Spielman WS. Adenosine-induced decrease in renin release: dissociation from hemodynamics effects. Am J Physiol. 1984;247:F447-F452.
32.
Churchill PC, Churchill MC. A1 and
A2 adenosine receptor activation inhibits and
stimulates renin secretion of rat renal cortical slices.
J Pharmacol Exp Ther. 1985;232:589-594.
This article has been cited by other articles:
![]() |
R. W. Schrier Blood Urea Nitrogen and Serum Creatinine: Not Married in Heart Failure Circ Heart Fail, May 1, 2008; 1(1): 2 - 5. [Full Text] [PDF] |
||||
![]() |
S. N. Orlov and A. A. Mongin Salt-sensing mechanisms in blood pressure regulation and hypertension Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2039 - H2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Costanzo, M. E. Guglin, M. T. Saltzberg, M. L. Jessup, B. A. Bart, J. R. Teerlink, B. E. Jaski, J. C. Fang, E. D. Feller, G. J. Haas, et al. Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure J. Am. Coll. Cardiol., February 13, 2007; 49(6): 675 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Schrier Role of Diminished Renal Function in Cardiovascular Mortality: Marker or Pathogenetic Factor? J. Am. Coll. Cardiol., January 3, 2006; 47(1): 1 - 8. [Abstract] [Full Text] |
||||
![]() |
H. Castrop, J. N. Lorenz, P. B. Hansen, U. Friis, D. Mizel, M. Oppermann, B. L. Jensen, J. Briggs, O. Skott, and J. Schnermann Contribution of the basolateral isoform of the Na-K-2Cl- cotransporter (NKCC1/BSC2) to renin secretion Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1185 - F1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schweda, J. Klar, S. Narumiya, R. M. Nusing, and A. Kurtz Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys Am J Physiol Renal Physiol, September 1, 2004; 287(3): F427 - F433. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schweda, M. Kammerl, C. Wagner, B. K. Kramer, and A. Kurtz Upregulation of macula densa cyclooxygenase-2 expression is not dependent on glomerular filtration Am J Physiol Renal Physiol, July 1, 2004; 287(1): F95 - F101. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Castrop, F. Schweda, D. Mizel, Y. Huang, J. Briggs, A. Kurtz, and J. Schnermann Permissive role of nitric oxide in macula densa control of renin secretion Am J Physiol Renal Physiol, May 1, 2004; 286(5): F848 - F857. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aviv, N. K. Hollenberg, and A. Weder Urinary Potassium Excretion and Sodium Sensitivity in Blacks Hypertension, April 1, 2004; 43(4): 707 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schnermann The Juxtaglomerular Apparatus: From Anatomical Peculiarity to Physiological Relevance J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1681 - 1694. [Full Text] [PDF] |
||||
![]() |
F. Schweda, C. Wagner, B. K. Kramer, J. Schnermann, and A. Kurtz Preserved macula densa-dependent renin secretion in A1 adenosine receptor knockout mice Am J Physiol Renal Physiol, April 1, 2003; 284(4): F770 - F777. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Harris and M. D. Breyer Physiological regulation of cyclooxygenase-2 in the kidney Am J Physiol Renal Physiol, July 1, 2001; 281(1): F1 - F11. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Laamarti, P. D. Bell, and J.-Y. Lapointe Transport and regulatory properties of the apical Na-K-2Cl cotransporter of macula densa cells Am J Physiol Renal Physiol, November 1, 1998; 275(5): F703 - F709. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Wilcox, X. Deng, and W. J. Welch NO generation and action during changes in salt intake: roles of nNOS and macula densa Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1588 - R1593. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schnermann Juxtaglomerular cell complex in the regulation of renal salt excretion Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R263 - R279. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |